ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,737.10
-0.31%
S&P ASX All Technology
3,040.10
-0.87%
Brent Oil
76.805
-1.71%
US Dollar vs AUD
1.50509
0.69%
Bitcoin
69,214.43
0.60%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Adagene Inc (ADAG)

  7. Adagene Inc (ADAG) News

ADAG

Adagene (ADAG)

Adagene Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ADAG
DateTimeSourceHeadlineSymbolCompany
23/05/202406:45GlobeNewswire Inc.Adagene to Present at Investor Conferences in JuneNASDAQ:ADAGAdagene Inc
30/03/202400:00GlobeNewswire Inc.Adagene Reports Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:ADAGAdagene Inc
08/03/202408:01GlobeNewswire Inc.Adagene Appoints Heinz-Josef Lenz, M.D., FACP to Scientific and Strategic Advisory BoardNASDAQ:ADAGAdagene Inc
02/03/202408:30Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ADAGAdagene Inc
28/02/202400:00GlobeNewswire Inc.Adagene to Present at the Leerink Partners Global Biopharma Conference 2024NASDAQ:ADAGAdagene Inc
09/02/202422:08Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ADAGAdagene Inc
09/02/202422:00GlobeNewswire Inc.Adagene Announces Progress and Expansion of Clinical Collaboration Program for Masked, Anti-CTLA-4 SAFEbody® ADG126 (muzastotug) in Combination with KEYTRUDA® (pembrolizumab) to Demonstrate Further Efficacy in Patients with Metastatic Microsatellite-stabNASDAQ:ADAGAdagene Inc
17/01/202409:01GlobeNewswire Inc.Adagene Presents Interim Results Reinforcing Best-in-Class Profile of Masked anti-CTLA-4 SAFEbody® ADG126 (muzastotug) in Combination with Pembrolizumab in Metastatic Microsatellite-stable (MSS) Colorectal Cancer (CRC)NASDAQ:ADAGAdagene Inc
17/01/202409:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ADAGAdagene Inc
04/01/202421:00GlobeNewswire Inc.Adagene To Present Interim Results of Masked anti-CTLA-4 SAFEbody® ADG126 (muzastotug) in Combination with Pembrolizumab in MSS CRC at ASCO-GI SymposiumNASDAQ:ADAGAdagene Inc
04/11/202303:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ADAGAdagene Inc
04/11/202303:00GlobeNewswire Inc.Adagene Presents Data Demonstrating the Best-in-Class Therapeutic Index for Masked Anti-CTLA-4 SAFEbody® ADG126 at SITC 2023NASDAQ:ADAGAdagene Inc
12/10/202323:00GlobeNewswire Inc.Adagene Announces Poster Presentation on Optimal Dose Selection for Masked Anti-CTLA-4 SAFEbody® ADG126 at Upcoming Society for Immunotherapy of Cancer (SITC) 38th Annual MeetingNASDAQ:ADAGAdagene Inc
29/09/202320:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ADAGAdagene Inc
07/09/202320:00GlobeNewswire Inc.Adagene to Present at Investor and Scientific Conferences in SeptemberNASDAQ:ADAGAdagene Inc
31/08/202321:32GlobeNewswire Inc.Adagene Reports Six Month Financial Results for 2023 and Provides Corporate UpdateNASDAQ:ADAGAdagene Inc
31/08/202321:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ADAGAdagene Inc
08/07/202306:34Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ADAGAdagene Inc
04/05/202323:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ADAGAdagene Inc
04/05/202323:00GlobeNewswire Inc.Adagene Achieves $3 Million Milestone in Collaboration with Exelixis for Successful Nomination of Second SAFEbody® Novel Masked Antibody-Drug ConjugateNASDAQ:ADAGAdagene Inc
28/04/202321:06Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ADAGAdagene Inc
28/04/202321:03Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:ADAGAdagene Inc
28/04/202321:00GlobeNewswire Inc.Adagene Announces Updates to its Board of DirectorsNASDAQ:ADAGAdagene Inc
18/04/202323:27Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ADAGAdagene Inc
18/04/202323:17GlobeNewswire Inc.Adagene Presents Clinical Data for Anti-CTLA-4 SAFEbody® ADG126 Reinforcing Best-in-Class Safety Profile at Repeat Doses and Showing Early Efficacy Profile in Advanced/Metastatic Solid TumorsNASDAQ:ADAGAdagene Inc
29/03/202308:07Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ADAGAdagene Inc
29/03/202307:30GlobeNewswire Inc.Adagene Reports Full Year 2022 Financial Results and Provides Corporate UpdateNASDAQ:ADAGAdagene Inc
15/03/202309:00GlobeNewswire Inc.Adagene Announces Poster Presentations on Anti-CTLA-4 SAFEbody®, ADG126, at Upcoming American Association for Cancer Research (AACR) Annual Meeting in AprilNASDAQ:ADAGAdagene Inc
06/03/202311:39GlobeNewswire Inc.Adagene Appoints Professor Aurélien Marabelle to Scientific and Strategic Advisory BoardNASDAQ:ADAGAdagene Inc
10/02/202300:16Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ADAGAdagene Inc
 Showing the most relevant articles for your search:NASDAQ:ADAG

Your Recent History

FX
AUDJPY
AUD vs Yen
ASX
XFL
S&P ASX 50
NYSE
MCD
McDonalds
ASX
XJO
S&P ASX 200
NASDAQ
NVDA
NVIDIA
ASX
WOW
Woolworths
SPI
SP500
S&P 500
NYSE
XOM
Exxon Mobil
ASX
SUN
Suncorp
NYSE
NKE
Nike
ASX
WBC
Westpac Banking
COIN
BTCUSD
Bitcoin
ASX
TLS
Telstra
FX
AUDCAD
AUD vs CAD
NASDAQ
MSFT
Microsoft
ASX
ANZ
Australia And New Zealan...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved